Papillary Renal Cell Carcinoma

• CLINICAL_TRIALS trial_result · 2017-06-14
  Clinical Trial Update: Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors [Phase 2]

  Phase 2 clinical trial evaluating combination chemotherapy, radiation therapy, and/or surgery for high-risk pediatric kidney tumors; results…

• CLINICAL_TRIALS trial_result · 2015-11-26
  Clinical Trial Update: RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe [Phase 2]

  Phase 2 trial RAPTOR evaluated RAD001 (everolimus) as monotherapy for advanced papillary renal cell carcinoma; the study is completed with r…

• CLINICAL_TRIALS trial_result · 2013-07-02
  Clinical Trial Update: Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer [Phase 2]

  Phase 2 clinical trial evaluating sorafenib in combination with interferon alfa-2b for locally advanced or metastatic renal cell carcinoma; …

• CLINICAL_TRIALS trial_result · 2013-06-28
  Clinical Trial Update: Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer [Phase 1, Phase 2]

  A Phase 1/Phase 2 trial evaluating the combination of sorafenib tosylate and bevacizumab in advanced renal cell carcinoma, with results post…

• CLINICAL_TRIALS trial_result · 2013-02-28
  Clinical Trial Update: Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer [Phase 2]

  A Phase 2 trial evaluating erlotinib for locally advanced or metastatic papillary renal cell carcinoma has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.